Skip to content
Beacon

ELILDirexion Daily LLY Bull 2X Shares

Take a bet1y track recordRanked #471 of 948 in this goal

Seeks daily investment results of 200% of the daily performance of LLY.

By Direxion Funds · Launched 2025

Annual Cost

1.07%

#5,372 of 5,853 · expensive

Fund Size

$23M

#4,348 of 5,853 · small

Return (1Y)Goal

+81.5%

Track Record

1 year

#4,181 of 5,853 · young

Performance

Total-return NAV · USD
Growth of $10,000
$19,097+91.0%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Strategy

Leveraged

What it actually holds

By weight

Concentration

single-stock bet — holdings shown are derivatives collateral, not diversification

GOLDMAN SACHS LIQ ES FD A
27.9%
DREYFUS
17.9%
DREYFUS GOVERNMENT CASH MANAGE
15.7%
ELI LILLY & COMPANY
15.3%
GOLDMAN FINANCIAL
11.0%
N/A
0.9%
N/A
-1.0%
N/A
-1.5%
N/A
-2.5%

Asset allocation

Stocks
52.4%
Cash
47.6%

By sector

Healthcare
100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
76.2%High

Year-on-year price swings

Max drawdown
-56.0%Severe

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Listing

Exchange
NASDAQ Global Select Market

Full fund details

Objective
Seeks daily investment results of 200% of the daily performance of LLY.
Strategy
Invests at least 80% of net assets in securities of LLY and financial instruments, such as swap agreements, to provide 2X daily leveraged exposure to LLY. Concentrated in the healthcare sector and pharmaceutical industry, with daily rebalancing to maintain exposure.
Inception date
March 25, 2025
Fund family
Direxion Funds

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged single stock
Critical

Most of these lose money

These funds amplify one stock's daily move, then reset every day. More than half of them have lost money outright, and the daily reset plus financing costs drag roughly 9.5% a year off the return. The longer you hold, the more that compounding works against you.

Sources: Bessembinder, 'Leveraged Single-Stock ETFs' (SSRN 2025)

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've looked at ELIL. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

See other funds for this goal

Data updated on 2026-08-02